Click to search for your profile
Click to search for condition or expert
Click to open main menu
Save Condition
Bookmark
Share
Share
Condition
Latest Advances in
Non-Small Cell Lung Cancer
Overview
Find a Doctor
Latest Advances
Clinical Trials
Latest Advances
Filter
Journal:
Cells
Published —
April 03, 2021
Constitutive Cell Proliferation Regulating Inhibitor of Protein Phosphatase 2A (CIP2A) Mediates Drug Resistance to Erlotinib in an EGFR Activating Mutated NSCLC Cell Line.
Condition:
Non-Small Cell Lung Cancer
Journal:
Journal for immunotherapy of cancer
Treatment Used:
Atezolizumab
Number of Patients:
619
Published —
March 19, 2021
The study researched the use of atezolizumab in treating non-small cell lung cancer.
Condition:
Advanced Epidermal Growth Factor Receptor Mutation Positive Non-Squamous Non-Small Cell Lung Cancer
Journal:
The Cochrane database of systematic reviews
Treatment Used:
Chemotherapy
Number of Patients:
3023
Published —
March 18, 2021
The study researched the use of chemotherapy in patients with advanced epidermal growth factor receptor mutation positive non-squamous non-small cell lung cancer.
Condition:
Primary Pulmonary Lymphoepithelioma-Like Carcinoma (PPLELC)
Journal:
Medicine
Treatment Used:
Neoadjuvant Treatment
Number of Patients:
1
Published —
March 17, 2021
This case report describes a 46-year-old male diagnosed with primary pulmonary lymphoepithelioma-like carcinoma (PPLELC) treated with Sintilimab combined with gemcitabine plus nedaplatin chemotherapy (GP) regimen, supplemented with antiemetics and stomach protection drugs.
Condition:
Non-Small Cell Lung Cancer (NSCLC)
Journal:
Scientific reports
Treatment Used:
Curative and Palliative Radiation Therapy
Number of Patients:
50
Published —
March 16, 2021
This review of the literature evaluated and compared the toxicity rates of curative and palliative radiotherapy with and without chemotherapy in patients with non-small cell lung cancer (NSCLC).
Condition:
EGFR-TKI-Resistant Advanced Non-Small Cell Lung Cancer
Journal:
Journal of B.U.ON. : official journal of the Balkan Union of Oncology
Treatment Used:
Osimertinib
Number of Patients:
84
Published —
March 15, 2021
The aim of this study was to explore the effectiveness and safety of Osimertinib in the treatment of patients with first-generation EGFR-TKI-resistant advanced non-small cell lung cancer (NSCLC).
Condition:
Advanced Non-Small Cell Lung Cancer (NSCLC)
Journal:
Current oncology (Toronto, Ont.)
Treatment Used:
Systemic Treatment
Number of Patients:
1084
Published —
March 11, 2021
This study explored systemic therapy uptake and survival in patients with advanced non-small lung cancer (NSCLC).
Condition:
Non-small Cell Lung Cancer
Journal:
Medicine
Treatment Used:
Afatinib and Bevacizumab
Number of Patients:
1
Published —
March 05, 2021
In this study, researchers evaluated the outcomes of using afatinib and bevacizumab for the treatment of a EGFR-mutated non-small cell lung cancer patient with acquired ERBB2 amplification.
Condition:
Non-Small Cell Lung Cancer
Journal:
Jornal brasileiro de pneumologia : publicacao oficial da Sociedade Brasileira de Pneumologia e Tisilogia
Treatment Used:
Adjuvant Chemotherapy
Number of Patients:
231
Published —
March 03, 2021
This study aimed to evaluate the effectiveness, safety, and feasibility of adjuvant chemotherapy (AC) for non-small cell lung cancer (NSCLC) patients.
Condition:
Oligometastatic Disease in Patients with Non-Small Cell Lung Cancer
Journal:
European respiratory review : an official journal of the European Respiratory Society
Treatment Used:
Surgery and Radiotherapy, Local Therapy Combined with Systemic Therapy
Number of Patients:
0
Published —
March 02, 2021
This review summarized the current treatments for oligometastatic disease in patients with non-small cell lung cancer.
Condition:
Malignant Tumors
Journal:
Journal of the College of Physicians and Surgeons--Pakistan : JCPSP
Treatment Used:
Standardised Treatments Combined with Ubenimex
Number of Patients:
1372
Published —
March 01, 2021
The study researched the outcomes of standardized treatments combined with ubenimex for treating malignant tumors.
Condition:
Stage IV Large Cell Neuroendocrine Carcinoma of the Lung.
Journal:
Asian Pacific journal of cancer prevention : APJCP
Treatment Used:
Immunotherapy
Number of Patients:
37
Published —
February 28, 2021
This study defined the role of immunotherapy in the treatment of patients with large cell neuroendocrine carcinoma (LCNEC).
Showing 1-12 of 1097
Next